Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
---|
Total Revenue
|
29,420,000
|
30,045,000
|
29,007,000
|
28,552,000
| Cost of Revenue | 10,932,000 | 13,069,000 | 10,991,000 | 10,896,000 | |
Gross Profit
|
18,488,000
|
16,976,000
|
18,016,000
|
17,656,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 8,148,000 | 16,008,000 | 8,366,000 | 7,877,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 4,118,000 | 4,137,000 | 4,167,000 | 4,128,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
6,222,000
|
(3,169,000)
|
5,483,000
|
5,651,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 39,000 | (1,079,000) | 10,000 | 34,000 |
|
Earnings Before Interest And Taxes | 6,256,000 | (4,161,000) | 5,555,000 | 5,757,000 |
|
Interest Expense | 537,000 | 575,000 | 632,000 | 679,000 |
|
Income Before Tax | 5,719,000 | (4,736,000) | 4,923,000 | 5,078,000 |
|
Income Tax Expense | 864,000 | (2,810,000) | 631,000 | 793,000 |
|
Minority Interest | (2,903,000) | (2,303,000) | (2,699,000) | (2,460,000) |
|
|
|
Net Income From Continuing Ops | 1,947,000 | (4,142,000) | 1,655,000 | 1,897,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
1,952,000
|
(4,229,000)
|
1,593,000
|
1,825,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
1,952,000
|
(4,229,000)
|
1,593,000
|
1,825,000
|
|